Octagon Capital Advisors »

Ocular Therapeutix shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $21M 2.4M 8.70
2024-06-30 $17M 2.4M 6.84
2024-03-31 $22M 2.4M 9.10

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
BlackRock
Vanguard Group
TCG Crossover Management
Logos Global Management
Opaleye Management
Citadel Advisors
State Street Corporation
Perceptive Advisors
Geode Capital Management
Assenagon Asset Management
Deltec Asset Management

View all funds holding Ocular Therapeutix